Imaging of melanoma: usefulness of ultrasonography before and after contrast injection for diagnosis and early evaluation of treatment

Por Chami, Linda, Lassau, Nathalie, Chebil, Mohamed, Robert, Caroline
Publicado em 2011

Harnessing the immune system to provide long-term survival in patients with melanoma and other solid tumors

Por Eggermont, Alexander, Robert, Caroline, Soria, Jean Charles, Zitvogel, Laurence
Publicado em 2014

Metastatic melanoma: New paradigms of treatment and new toxicities

Por Robert, Caroline, Mateus, Christina, Routier, Emilie, Thomas, Marina, Boussemart, Lise, Eggermont, Alexander M.
Publicado em 2013

Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors

Por Brendel, Erich, Ludwig, Matthias, Lathia, Chetan, Robert, Caroline, Ropert, Stanislas, Soria, Jean-Charles, Armand, Jean-Pierre
Publicado em 2010

Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion

Por Ziani, Linda, Safta-Saadoun, Thouraya Ben, Gourbeix, Johanne, Cavalcanti, Andrea, Robert, Caroline, Favre, Gilles, Chouaib, Salem, Thiery, Jerome
Publicado no Oncotarget (2017)

Seminal vesicle metastasis of cutaneous malignant melanoma: An unusual and challenging presentation

Por Foahom Kamwa, Alain D., Mateus, Christine, Thanigasalam, Ruban, Boulay-Coletta, Isabelle, Duchatelle, Véronique, Triller, Marie, Robert, Caroline, Baumert, Hervé
Publicado no Can Urol Assoc J (2015)

Synergistic effects of eIF4A and MEK inhibitors on proliferation of NRAS-mutant melanoma cell lines

Por Malka-Mahieu, Hélène, Girault, Isabelle, Rubington, Margot, Leriche, Melissa, Welsch, Caroline, Kamsu-Kom, Nyam, Zhao, Qian, Desaubry, Laurent, Vagner, Stéphan, Robert, Caroline
Publicado no Cell Cycle (2016)

Interaction of Dendritic Cells with Skin Endothelium: A New Perspective on Immunosurveillance

Por Robert, Caroline, Fuhlbrigge, Robert C., Kieffer, J. David, Ayehunie, Seyoum, Hynes, Richard O., Cheng, Guiying, Grabbe, Stephan, von Andrian, Ulrich H., Kupper, Thomas S.
Publicado em 1999

Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma

Por Kirkwood, John M., Bastholt, Lars, Robert, Caroline, Sosman, Jeff, Larkin, James, Hersey, Peter, Middleton, Mark, Cantarini, Mireille, Zazulina, Victoria, Kemsley, Karin, Dummer, Reinhard
Publicado em 2011

Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies

Por Grande, Enrique, Kreissl, Michael C., Filetti, Sebastiano, Newbold, Kate, Reinisch, Walter, Robert, Caroline, Schlumberger, Martin, Tolstrup, Lærke K., Zamorano, Jose L., Capdevila, Jaume
Publicado em 2013

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Por Schadendorf, Dirk, Hodi, F. Stephen, Robert, Caroline, Weber, Jeffrey S., Margolin, Kim, Hamid, Omid, Patt, Debra, Chen, Tai-Tsang, Berman, David M., Wolchok, Jedd D.
Publicado no J Clin Oncol (2015)

Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα

Por Viaud, Sophie, Terme, Magali, Flament, Caroline, Taieb, Julien, André, Fabrice, Novault, Sophie, Escudier, Bernard, Robert, Caroline, Caillat-Zucman, Sophie, Tursz, Thomas, Zitvogel, Laurence, Chaput, Nathalie
Publicado em 2009

MHC Class I-Related Neonatal Fc Receptor for IgG Is Functionally Expressed in Monocytes, Intestinal Macrophages, and Dendritic Cells

Por Zhu, Xiaoping, Meng, Gang, Dickinson, Bonny L., Li, Xiaotong, Mizoguchi, Emiko, Miao, Lili, Wang, Yuansheng, Robert, Caroline, Wu, Benyan, Smith, Phillip D., Lencer, Wayne I., Blumberg, Richard S.
Publicado em 2001

Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients: IL-2 interferes with the pharmacokinetics of imatinib mesylate

Por Pautier, Patricia, Locher, Clara, Robert, Caroline, Deroussent, Alain, Flament, Caroline, Le Cesne, Axel, Rey, Annie, Bahleda, Ratislav, Ribrag, Vincent, Soria, Jean-Charles, Vassal, Gilles, Eggermont, Alexander, Zitvogel, Laurence, Chaput, Nathalie, Paci, Angelo
Publicado em 2013

Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma

Por Wolchok, Jedd D, Hodi, F Stephen, Weber, Jeffrey S, Allison, James P, Urba, Walter J, Robert, Caroline, O'Day, Steven J, Hoos, Axel, Humphrey, Rachel, Berman, David M, Lonberg, Nils, Korman, Alan J
Publicado em 2013

Molecular Characterization and Patient Outcome of Melanoma Nodal Metastases and an Unknown Primary Site

Por Gos, Aleksandra, Jurkowska, Monika, van Akkooi, Alexander, Robert, Caroline, Kosela-Paterczyk, Hanna, Koljenović, Senada, Kamsukom, Nyam, Michej, Wanda, Jeziorski, Arkadiusz, Pluta, Piotr, Verhoef, Cornelis, Siedlecki, Janusz A., Eggermont, Alexander M. M., Rutkowski, Piotr
Publicado no Ann Surg Oncol (2014)

Senescent cells develop a PARP-1 and nuclear factor-κB-associated secretome (PNAS)

Por Ohanna, Mickaël, Giuliano, Sandy, Bonet, Caroline, Imbert, Véronique, Hofman, Véronique, Zangari, Joséphine, Bille, Karine, Robert, Caroline, Bressac-de Paillerets, Brigitte, Hofman, Paul, Rocchi, Stéphane, Peyron, Jean-François, Lacour, Jean-Philippe, Ballotti, Robert, Bertolotto, Corine
Publicado em 2011

Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR(+) NK cell levels correlate with disease outcome

Por Chaput, Nathalie, Flament, Caroline, Locher, Clara, Desbois, Mélanie, Rey, Annie, Rusakiewicz, Sylvie, Poirier-Colame, Vichnou, Pautier, Patricia, Le Cesne, Axel, Soria, Jean-Charles, Paci, Angelo, Rosenzwajg, Michelle, Klatzmann, David, Eggermont, Alexander, Robert, Caroline, Zitvogel, Laurence
Publicado em 2013

RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors

Por Oberholzer, Patrick A., Kee, Damien, Dziunycz, Piotr, Sucker, Antje, Kamsukom, Nyam, Jones, Robert, Roden, Christine, Chalk, Clinton J., Ardlie, Kristin, Palescandolo, Emanuele, Piris, Adriano, MacConaill, Laura E., Robert, Caroline, Hofbauer, Günther F.L., McArthur, Grant A., Schadendorf, Dirk, Garraway, Levi A.
Publicado em 2012

Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials

Por Flaherty, Keith T, Hennig, Michael, Lee, Sandra J, Ascierto, Paolo A, Dummer, Reinhard, Eggermont, Alexander M M, Hauschild, Axel, Kefford, Richard, Kirkwood, John M, Long, Georgina V, Lorigan, Paul, Mackensen, Andreas, McArthur, Grant, O'Day, Steven, Patel, Poulam M, Robert, Caroline, Schadendorf, Dirk
Publicado no Lancet Oncol (2014)